Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets

PURPOSE: It is projected that approximately 50,000 new cases of prostate cancer will be diagnosed in 2020 in India. Survival has improved because of the development of effective drugs such as abiraterone acetate, but universal accessibility to treatment is not always possible because of cost constra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCO Glob Oncol
Main Authors: Patel, Amol, Tannock, Ian F., Srivastava, Priyanka, Biswas, Bivas, Gupta, Vineet Govinda, Batra, Atul, Bhethanabhotla, Sainath, Pramanik, Raja, Mahindru, Shubh, Tilak, TVSVGK, Das, Chandan Krishna, Mehta, Prashant
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2020
Assuntos:
Special Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7113122/
https://ncbi.nlm.nih.gov/pubmed/32125899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JGO.19.00341
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados